Nano-size particles show promise for pulmonary drug delivery, yet their behavior after
deposition in the lung remains poorly understood. In this study, a series of near-infrared …

The advent of nanotechnology has reignited interest in the lungs as a major route of drug
delivery for both systemic and local treatments. The large surface area of the lungs and the …

Nanoparticles (NP), here defined as particles with a diameter smaller then 100 nm, are
increasingly used in different applications, including drug carrier systems and to pass organ …

Inhaled drug delivery has been an emerging route for the treatment of lung diseases with
clear advantages over oral and intravenous routes. However, the delivery efficacy is affected …

The rapid development of nanotechnology is opening a huge world of promising
possibilities in healthcare, but this is also increasing the necessity to study the potential risk …

Pulmonary tuberculosis is a highly prevalent respiratory disease that affects approximately a
quarter of the world's population. The drug treatment protocol for tuberculosis is complex …

The purpose of this review is to discuss the impact of nanocarriers administered by
pulmonary route to treat and to diagnose respiratory and non respiratory diseases. Indeed …

Introduction: Pulmonary route is one of the preferred routes for the administration of
therapeutically active agents for systemic as well as localized delivery. Chronic obstructive …

Interaction with the pulmonary surfactant film, being the first line of host defense, represents
the initial bio-nano interaction in the lungs. Such interaction determines the fate of the …

Spray-drying is a common practice of powder preparation for a wide range of drugs. Spray-
dried powders can be used to deliver particles to the lungs via a dry powder inhaler (DPI) …